Estradiol/norethisterone transdermal - Solvay
Alternative Names: Bio-E/P-Gel; E2/NETA gel - Solvay; Estradiol/NETA - Solvay; Estradiol/norethisterone gel - Solvay; Estradiol/progestogen gel - SolvayLatest Information Update: 26 May 2022
At a glance
- Originator Antares Pharma; BioSante Pharmaceuticals
- Class Estradiol congeners; Estrenes; Hormonal contraceptives; Hormonal replacements; Norpregnenes; Oral contraceptives; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Menopausal syndrome
Most Recent Events
- 24 May 2022 Antares Pharma has been acquired by Halozyme Therapeutics
- 23 Mar 2007 Discontinued - Phase-I for Menopausal syndrome in World (Transdermal)
- 23 Mar 2007 Discontinued - Phase-II/III for Menopausal syndrome in USA (Transdermal)